ORGANOGENESIS HOLDINGS INC. Increase (Decrease) in Inventories
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Increase (Decrease) in Inventories of $11.81 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was $3.08M, a 56.96% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $8.73M, a 0.02% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was $2.96M, a 550.77% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$938.00K, a 125.08% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in inventories for fiscal 2025 was $17.91M, a 188.77% increase from fiscal 2024.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in inventories for fiscal 2024 was $6.20M, a 24.15% decline from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in inventories for fiscal 2023 was $8.18M, a 13.08% decline from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. increase (decrease) in inventories for fiscal 2022 was $9.41M, a 1.16% increase from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 3 month as first filed | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $11.81M 10-Q · filed 2026-08-06 | $14.77M derived: sum of 3 quarters · filed 2026-08-06 | $13.84M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $8.73M 10-Q · filed 2026-05-07 | $11.69M derived: sum of 2 quarters · filed 2026-05-07 | $10.75M derived: sum of 3 quarters · filed 2026-05-07 | $17.91M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.02M derived: sum of 2 quarters · filed 2026-02-26 | $9.18M derived: sum of 3 quarters · filed 2026-08-06 | $17.91M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | -$938.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $6.22M derived: sum of 2 quarters · filed 2026-08-06 | $14.95M 10-Q · filed 2025-11-06 | $15.41M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $7.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $15.89M 10-Q · filed 2026-08-06 | $16.35M derived: sum of 3 quarters · filed 2026-08-06 | $20.09M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $8.73M 10-Q · filed 2026-05-07 | $9.19M derived: sum of 2 quarters · filed 2026-05-07 | $12.93M derived: sum of 3 quarters · filed 2026-05-07 | $10.27M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $455.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.20M derived: sum of 2 quarters · filed 2026-02-26 | $1.53M derived: sum of 3 quarters · filed 2026-02-26 | $6.20M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $3.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.08M derived: sum of 2 quarters · filed 2025-11-06 | $5.75M 10-Q · filed 2025-11-06 | $6.46M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | -$2.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.01M 10-Q · filed 2025-08-07 | $2.71M derived: sum of 3 quarters · filed 2026-02-26 | $6.14M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $4.67M 10-Q · filed 2025-05-08 | $5.38M derived: sum of 2 quarters · filed 2026-02-26 | $8.80M derived: sum of 3 quarters · filed 2026-02-26 | $10.69M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $706.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.13M derived: sum of 2 quarters · filed 2026-02-26 | $6.02M derived: sum of 3 quarters · filed 2026-02-26 | $8.18M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $3.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $5.31M derived: sum of 2 quarters · filed 2024-11-12 | $7.47M 10-Q · filed 2024-11-12 | $9.60M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $4.04M 10-Q · filed 2024-08-08 | $6.17M derived: sum of 3 quarters · filed 2025-02-27 | $10.01M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $2.16M 10-Q · filed 2024-05-09 | $4.29M derived: sum of 2 quarters · filed 2025-02-27 | $8.13M derived: sum of 3 quarters · filed 2025-02-27 | $11.65M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $5.97M derived: sum of 2 quarters · filed 2025-02-27 | $9.49M derived: sum of 3 quarters · filed 2025-02-27 | $9.41M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $3.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $7.36M derived: sum of 2 quarters · filed 2023-11-09 | $7.28M 10-Q · filed 2023-11-09 | $6.84M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $3.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $3.44M 10-Q · filed 2023-08-09 | $3.00M derived: sum of 3 quarters · filed 2024-02-29 | $7.76M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | -$80.00K 10-Q · filed 2023-05-10 | -$519.00K derived: sum of 2 quarters · filed 2024-02-29 | $4.24M derived: sum of 3 quarters · filed 2024-02-29 | $5.01M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | -$439.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $4.32M derived: sum of 2 quarters · filed 2024-02-29 | $5.09M derived: sum of 3 quarters · filed 2024-02-29 | $9.30M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | $4.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $5.53M derived: sum of 2 quarters · filed 2022-11-09 | $9.74M 10-Q · filed 2022-11-09 | $8.68M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | $772.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $4.98M 10-Q · filed 2022-08-09 | $3.93M derived: sum of 3 quarters · filed 2023-03-01 | $4.33M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $4.21M 10-Q · filed 2022-05-10 | $3.15M derived: sum of 2 quarters · filed 2023-03-01 | $3.56M derived: sum of 3 quarters · filed 2023-03-01 | $6.63M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | -$1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$653.00K derived: sum of 2 quarters · filed 2023-03-01 | $2.41M derived: sum of 3 quarters · filed 2023-03-01 | $6.70M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | $404.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $3.47M derived: sum of 2 quarters · filed 2021-11-09 | $7.76M 10-Q · filed 2021-11-09 | $10.98M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $3.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $7.35M 10-Q · filed 2021-08-09 | $10.58M derived: sum of 3 quarters · filed 2022-03-01 | $12.33M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $4.29M 10-Q · filed 2021-05-11 | $7.51M derived: sum of 2 quarters · filed 2022-03-01 | $9.26M derived: sum of 3 quarters · filed 2022-03-01 | $10.27M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2019-12-31 | $3.22M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $4.98M derived: sum of 2 quarters · filed 2022-03-01 | $5.99M derived: sum of 3 quarters · filed 2022-03-01 | $11.06M 10-K · filed 2022-03-01 | ||
| 2019-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $2.76M derived: sum of 2 quarters · filed 2020-11-09 | $7.84M 10-Q · filed 2020-11-09 | $9.51M derived: sum of 4 quarters · filed 2021-03-16 | ||
| 2019-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $6.09M 10-Q · filed 2020-08-10 | $7.76M derived: sum of 3 quarters · filed 2021-03-16 | $5.96M derived: sum of 4 quarters · filed 2021-03-16 | ||
| 2019-03-31 | $5.08M 10-Q · filed 2020-05-11 | $5.34M 10-Q · filed 2019-05-10 | $6.75M derived: sum of 2 quarters · filed 2021-03-16 | $4.95M derived: sum of 3 quarters · filed 2021-03-16 | $4.32M derived: sum of 4 quarters · filed 2021-03-16 | |
| 2018-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | -$124.00K derived: sum of 2 quarters · filed 2021-03-16 | -$758.00K derived: sum of 3 quarters · filed 2021-03-16 | $1.52M 10-K · filed 2021-03-16 | $5.00M 10-K · filed 2019-03-18 | |
| 2018-09-30 | -$1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$2.43M derived: sum of 2 quarters · filed 2019-11-12 | -$145.00K 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | -$634.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.65M 10-Q · filed 2019-08-09 | ||||
| 2018-03-31 | $2.28M 10-Q · filed 2019-05-10 | |||||
| 2017-12-31 | $1.49M 10-K · filed 2020-03-09 | $3.82M 10-K · filed 2019-03-18 | ||||
| 2016-12-31 | $5.37M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |